FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998909972> ?p ?o ?g. }

• W1998909972 endingPage "A40" @default.
• W1998909972 startingPage "A39" @default.
• W1998909972 abstract "<h3>Aims</h3> The evidence base for the use of intravenous (IV) bronchodilator treatment in children with acute severe wheeze is limited. Thus, international guidelines vary with their recommendations. The aim of this evaluation was to examine the regimen currently used in emergency departments (EDs) of the UK and Ireland. <h3>Methods</h3> Demographic and clinical data along with IV treatment details were collected prospectively over a ten-week period (March–June 2013) from all children aged 1–16 years presenting with acute wheeze to 24 PERUKI (Paediatric Emergency Research in the UK and Ireland) centres. <h3>Results</h3> 3,297 children presented to the EDs. No nebulsed magnesium sulphate (MgSO₄) was used. 110 children (3.3%) received IV bronchodilators. Median age was 4 years. Girls [63/110 (57.3%)] were more likely to receive IV treatment (p < 0.001). IV salbutamol was used in 61/110 (55.5%), aminophylline 52/110 (47.3%) and MgSO₄, 67/110(60.9%) of cases. In 16.4%, all three drugs were administered and in 31.8%, two drugs were used together. Aminophylline, salbutamol and MgSO₄ were used as single agents in 21.8%, 17.3% and 12.7% respectively. MgSO₄ was administered concurrently with salbutamol in 7/25 (28%) of cases where these two drugs were used together. Order of preference, when used sequentially, was most commonly, salbutamol, MgSO₄ then aminophylline. Thirty different treatment IV regimens were used varying in dose, rate and duration (bolus, load and infusion) for salbutamol with variability in maximal doses given. Bolus MgSO₄ was used soley with no infusion although variable doses were used. Aminophylline was most commonly used as a bolus and infusion with similar doses in most cases. <h3>Conclusions</h3> There is huge variability in IV treatment regimen used for acute severe wheeze in children in the UK and Ireland. There is an urgent need for high quality randomised controlled trials to clarify, which is the safest and most effective regimen for this very sick group of children." @default.
• W1998909972 created "2016-06-24" @default.
• W1998909972 creator A5035201271 @default.
• W1998909972 creator A5037575744 @default.
• W1998909972 creator A5061435396 @default.
• W1998909972 creator A5069807652 @default.
• W1998909972 creator A5082196609 @default.
• W1998909972 date "2014-04-01" @default.
• W1998909972 modified "2023-09-26" @default.
• W1998909972 title "G92 What intravenous treatment is currently being administered for acute severe wheeze in childhood in emergency departments around the UK and Ireland?" @default.
• W1998909972 doi "https://doi.org/10.1136/archdischild-2014-306237.92" @default.
• W1998909972 hasPublicationYear "2014" @default.
• W1998909972 type Work @default.
• W1998909972 sameAs 1998909972 @default.
• W1998909972 citedByCount "1" @default.
• W1998909972 countsByYear W19989099722014 @default.
• W1998909972 crossrefType "journal-article" @default.
• W1998909972 hasAuthorship W1998909972A5035201271 @default.
• W1998909972 hasAuthorship W1998909972A5037575744 @default.
• W1998909972 hasAuthorship W1998909972A5061435396 @default.
• W1998909972 hasAuthorship W1998909972A5069807652 @default.
• W1998909972 hasAuthorship W1998909972A5082196609 @default.
• W1998909972 hasConcept C126322002 @default.
• W1998909972 hasConcept C187212893 @default.
• W1998909972 hasConcept C194828623 @default.
• W1998909972 hasConcept C2776042228 @default.
• W1998909972 hasConcept C2776202631 @default.
• W1998909972 hasConcept C2777394947 @default.
• W1998909972 hasConcept C2778338976 @default.
• W1998909972 hasConcept C2781018748 @default.
• W1998909972 hasConcept C2781413609 @default.
• W1998909972 hasConcept C42219234 @default.
• W1998909972 hasConcept C71924100 @default.
• W1998909972 hasConceptScore W1998909972C126322002 @default.
• W1998909972 hasConceptScore W1998909972C187212893 @default.
• W1998909972 hasConceptScore W1998909972C194828623 @default.
• W1998909972 hasConceptScore W1998909972C2776042228 @default.
• W1998909972 hasConceptScore W1998909972C2776202631 @default.
• W1998909972 hasConceptScore W1998909972C2777394947 @default.
• W1998909972 hasConceptScore W1998909972C2778338976 @default.
• W1998909972 hasConceptScore W1998909972C2781018748 @default.
• W1998909972 hasConceptScore W1998909972C2781413609 @default.
• W1998909972 hasConceptScore W1998909972C42219234 @default.
• W1998909972 hasConceptScore W1998909972C71924100 @default.
• W1998909972 hasIssue "Suppl 1" @default.
• W1998909972 hasLocation W19989099721 @default.
• W1998909972 hasOpenAccess W1998909972 @default.
• W1998909972 hasPrimaryLocation W19989099721 @default.
• W1998909972 hasRelatedWork W1998909972 @default.
• W1998909972 hasRelatedWork W2045850009 @default.
• W1998909972 hasRelatedWork W2065966192 @default.
• W1998909972 hasRelatedWork W2115808464 @default.
• W1998909972 hasRelatedWork W2125793831 @default.
• W1998909972 hasRelatedWork W2140081545 @default.
• W1998909972 hasRelatedWork W2319997442 @default.
• W1998909972 hasRelatedWork W2409144101 @default.
• W1998909972 hasRelatedWork W2563364729 @default.
• W1998909972 hasRelatedWork W4220938591 @default.
• W1998909972 hasVolume "99" @default.
• W1998909972 isParatext "false" @default.
• W1998909972 isRetracted "false" @default.
• W1998909972 magId "1998909972" @default.
• W1998909972 workType "article" @default.